COVID-19 Therapeutics

Suitecase

COVID-19 Therapeutics 

This webpage is for healthcare professionals and focuses on common antiviral treatments that can be used in the outpatient setting.

In brief, COVID-19 therapeutics are indicated for symptomatic patients with mild to moderate COVID-19 who are at increased risk for progression to severe disease. COVID-19 antiviral therapy has been shown to prevent worsening illness, and COVID-19-related hospitalizations and deaths. Drug therapy needs to be started quickly after the onset of symptoms. Use of these medications is considered a recommended practice for patients. 
 

Opens pdf to download

Opens in a new window

External link will open in a new window.  Click link to exit Virginia Department of Health Website. 

Last Updated: November 1, 2024